Global Glycobiology Market is valued approximately at USD 1.04 billion and is anticipated to grow with a healthy growth rate of more than 14.64 % over the forecast period. Glycobiology is the science of saccharides (sugar chains or glycans) formation, biosynthesis, and biology. Glycobiology is the science of whole biology and includes the structure and function of carbohydrate-containing molecules (sugar and saccharides) also known as glycans. Key driving forces of the market includes increase in funding for proteomics and glycomics studies, increase in investment for research and development and technological advancements in glycomics instrumentation. Additionally, advancement of biotechnology and proteomics in the R&D and pharmaceutical industry the demand is projected to create significant growth opportunity in the market over the forecast period. However, stringent regulatory frameworks and high degree of consolidation in the market is expected to create significant barrier in the market over the forecast period. Apart from this, the key players of global Glycobiology market have adopted various strategies to gain competitive advantage including product launch, mergers and acquisition, partnerships and agreements, investment, funding and others. For instance, Agilent Technologies (US) launched Infinity Lab LC / MSD iQ System in June 2019. In June 2018, Thermo Fisher Scientific (US) had introduced UHMR Hybrid Quadrupole-Orbitrap Mass Spectrometer. In 2018, Shimadzu Corp. partnered with PREMIER Biosoft, a multinational bioinformatics solutions firm, with the goal of launching its LCMS-9030 Quadrupole Time of Flight (Q-TOF) mass spectrometry system for advance glycomics and lipidomics data processing.
Click Here to Download Sample Report >> https://www.sdki.us/sample-request-58953
The regional analysis of global Glycobiology market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the presence of key pharmaceutical and biopharmaceutical companies in the region. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period. Factors such as evolving pharmaceutical and biopharmaceutical industries, investments by Contract Research Organizations (CROs), would create lucrative growth prospects for the Glycobiology market across Asia-Pacific region.
Major market player included in this report are:
Thermo Fisher Scientific
New England Biolabs
Asparia Glycomics S.L.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.
Glycobiology Market Size Inclinations And Development Status Highlighted During Forecast Period 2022-2031
Interventional Neurology Market Size: Key Facts and Forecast Predictions Presented 2022-2031
Neurorehabilitation Devices Market Size Global Industry Trends, Share, and Forecast Report 2022-2031
Defibrillators Market Size Report Analysis, Share, Revenue, Growth Rate With Forecast Overview 2022-2031
Bone Growth Stimulator Market Size By Key Players, Deployment Type, Applications, Vertical, and Region 2022-2031